Multiple Sclerosis Research Studies
Multiple Sclerosis Research Studies is a research topic within Pathology and Forensic Medicine. Science Explorer counts 37k research works in it since 1950. 20.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, pathogenesis, and treatment of multiple sclerosis (MS) and related disorders such as neuromyelitis optica. It covers topics such as the diagnostic criteria for MS, genetic risk factors, immune mechanisms involved in MS, cognitive impairment, axonal injury, and the autoimmune pathology underlying the disease. The papers also discuss the use of various therapies and their effects on MS patients.
- Multiple Sclerosis
- Diagnostic Criteria
- Neuromyelitis Optica
- Demyelination
- Immune Mechanisms
- Genetic Risk
- B-Cell Depletion
- Cognitive Impairment
- Axonal Injury
- Autoimmune Pathology
- Research works
- 37k fractional, since 1950
- In the world top 10%
- 7.7k per year above
- Top-10% rate
- 20.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +24% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Multiple Sclerosis Research Studies research?
By volume, the United States and China publish the most (1.6k and 571 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.6k works
- 2 China 571 works
- 3 Italy 502 works
- 4 Iran 434 works
- 5 Germany 409 works
- 6 United Kingdom 383 works
- 7 Spain 271 works
- 8 Türkiye 271 works
- 9 France 246 works
- 10 Canada 227 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Multiple Sclerosis Research Studies research?
By volume in 2022–2025, Tehran University of Medical Sciences publishes the most Multiple Sclerosis Research Studies research, followed by Isfahan University of Medical Sciences and Cleveland Clinic.
By volume, 2022–2025
- 1 Tehran University of Medical SciencesIran 64 works
- 2 Isfahan University of Medical SciencesIran 48 works
- 3 Cleveland ClinicUnited States 39 works
- 4 Karolinska InstitutetSweden 34 works
- 5 Ain Shams UniversityEgypt 32 works
- 6 University of California, San FranciscoUnited States 32 works
- 7 Harvard UniversityUnited States 31 works
- 8 Brigham and Women's HospitalUnited States 29 works
- 9 University College LondonUnited Kingdom 29 works
- 10 Vita-Salute San Raffaele UniversityItaly 28 works
Who are the leading researchers in Multiple Sclerosis Research Studies?
The most-cited researchers publishing on Multiple Sclerosis Research Studies include Cyrus Cooper, Mohammad Ali Sahraian and Sharareh Eskandarieh.
- 1 Cyrus Cooper United Kingdom 7.2k citations
- 2 Mohammad Ali Sahraian Iran 4.6k citations
- 3 Sharareh Eskandarieh Iran 4.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Multiple Sclerosis Research Studies research done?
The largest centres of Multiple Sclerosis Research Studies research in 2022–2025 are Tehran (Iran), London (United Kingdom), Beijing (China) and Rome (Italy). Among places with at least 20 works in it, it is an unusually large share of all research in Isfahan, Basel and Sfax.
Largest cities, 2022–2025
Where it is the local speciality
- IsfahanIR · 57.9 works12×
- BaselCH · 51.6 works11×
- SfaxTN · 28.2 works9.7×
Location quotient: how much more of its research is in Multiple Sclerosis Research Studies than the world average.
Where is the best place to study Multiple Sclerosis Research Studies?
Among universities, judged by research, Karolinska Institutet, University of Campania "Luigi Vanvitelli" and Vita-Salute San Raffaele University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Karolinska InstitutetSweden | 72.3 | 30.3% | 10.4× | 34 | +39.7% |
| 2 | University of Campania "Luigi Vanvitelli"Italy | 68.3 | 31.8% | 9.3× | 14 | +318.1% |
| 3 | Vita-Salute San Raffaele UniversityItaly | 67.9 | 27.1% | 28.9× | 28 | +82.7% |
| 4 | University of VeronaItaly | 62.8 | 34.0% | 8.3× | 15 | +114.8% |
| 5 | Medical University of ViennaAustria | 59.4 | 23.4% | 10.9× | 25 | -1.1% |
| 6 | Tehran University of Medical SciencesIran | 59.1 | 7.8% | 18.5× | 64 | +64.7% |
| 7 | University of California, San FranciscoUnited States | 58.6 | 32.3% | 6.7× | 32 | +29.6% |
| 8 | Isfahan University of Medical SciencesIran | 57.4 | 12.6% | 28.1× | 48 | +45.1% |
| 9 | Iran University of Medical SciencesIran | 55.7 | 13.1% | 8.9× | 18 | +345.3% |
| 10 | University of TasmaniaAustralia | 55.7 | 19.5% | 8.9× | 14 | +129.1% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Multiple Sclerosis Research Studies research growing?
Output in 2018–2022 was 24% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Multiple Sclerosis Research Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.